Close
Smartlab Europe
Achema middle east

IT & Data Management

From insight to action: How Agentic AI is transforming life sciences manufacturing

Pharmaceutical manufacturers are under mounting pressure to become faster and more agile, due to a rise in global demand for therapies in areas like oncology, weight loss and immune disorders. Meanwhile, labs and manufacturing lines continue to be hampered...

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's increasing reliance on cryogenic storage and transportation for advanced therapies, including cell and gene treatments, vaccines, and specialized biologics, presents unique challenges for maintaining the integrity of serialization systems, RFID...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry stands at the threshold of a transformative era where artificial intelligence and predictive analytics are fundamentally reshaping cold chain risk management strategies. The integration of AI technologies has evolved from...

Transforming Pharma Cold Chain Using IoT Real-Time Tracking

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry has witnessed a revolutionary transformation in cold chain management through the implementation of Internet of Things (IoT) sensors, which provide unprecedented visibility and control over temperature-sensitive products such as vaccines...

Pharma Supply Chain and Customs Clearance Solutions

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry faces unprecedented challenges in global supply chain management, particularly when navigating the complex landscape of international customs clearance for clinical trial materials and commercial drug batches. Customs delays can have...

Evolution of Regulatory Frameworks for Real-World Data

The pharmaceutical landscape has undergone a profound transformation as regulatory agencies worldwide embrace real-world data to support drug development and approval processes. This regulatory navigation real-world data paradigm requires pharmaceutical companies to master complex frameworks that balance scientific innovation...

Biomarker Discovery Digital Age Standardization Validation

The biomarker discovery digital standardization landscape represents one of the most rapidly expanding sectors in modern healthcare, with the global market projected to reach $318.76 billion by 2034 from $94.24 billion in 2025, reflecting a remarkable compound annual growth...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »